Article Details

Sensei Biotherapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights

Retrieved on: 2022-05-10 11:32:00

Tags for this article:

Click the tags to see associated articles and topics

Sensei Biotherapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights. View article details on hiswai:

Excerpt

Sensei continues preclinical studies to evaluate SNS-101, a monoclonal antibody targeting the immune checkpoint VISTA (V-domain Ig suppressor of T ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up